Key Takeaways
- Atif Malik from Citi launched coverage of CBRS with a Buy recommendation and the highest Wall Street price objective of $340, suggesting approximately 45.9% potential growth.
- Craig-Hallum initiated its own Buy rating with a $325 target, emphasizing that Cerebras’ wafer-scale architecture outperforms rival AI inference platforms in speed.
- Shares of CBRS declined 3.09% during Tuesday’s session, bringing total losses since the May 14 IPO launch at $350 to 23.54%.
- Major tech players including OpenAI and Amazon have chosen Cerebras for AI inference capabilities within the last half-year.
- Analyst consensus stands at Strong Buy across 10 ratings, with a mean price objective of $294 — representing approximately 27.69% upside potential from present trading levels.
Cerebras Systems (CBRS) made its public market debut on May 14, 2026, with shares priced at $350. The stock has since retreated 23.54%, hovering near $233 as of Tuesday’s close.
Yet despite this downturn, Wall Street analysts are delivering optimistic projections.
Citi analyst Atif Malik launched coverage with a Buy recommendation and established the Street’s most aggressive price target at $340. This target implies roughly 46% appreciation from where shares currently trade.
Craig-Hallum also initiated coverage with a Buy stance and $325 price objective. The research firm highlighted Cerebras’ proprietary wafer-scale computing architecture, noting it provides superior AI inference performance compared to competitive offerings available today.
Cerebras engineered the planet’s first wafer-scale computing platform — a processor that utilizes an entire silicon wafer instead of being divided into separate chips.
Malik forecasts that Cerebras will secure between 40% and 50% of the rapid inference segment. Given his total addressable market estimate of $130 billion, this translates to potential revenue ranging from $52 billion to $65 billion.
Craig-Hallum projects an even larger opportunity — estimating the AI inference market will surpass $250 billion before 2030 arrives.
Major Technology Partners Validate Cerebras’ Approach
Both OpenAI and Amazon designated Cerebras as their inference provider during the previous six-month period. According to Craig-Hallum, these partnerships demonstrate to the broader market that Cerebras represents a credible substitute to established solutions.
The research firm observed that processing speed has emerged as a critical competitive advantage in artificial intelligence — referencing recent model releases that command premium pricing specifically for accelerated response capabilities.
Cerebras generated $510 million in revenue over the trailing twelve months, reflecting 76% year-over-year expansion. The company has already achieved positive earnings.
This profitability milestone is uncommon for a recently public enterprise.
Broadening Analyst Support
Multiple additional research firms launched coverage concurrent with Citi and Craig-Hallum.
Needham assigned CBRS a Buy rating alongside a $300 price target, emphasizing its exclusive position as the only manufacturer of Wafer-Scale Engines. Rosenblatt similarly rated it Buy at $300, spotlighting capabilities of its third-generation platform.
Wedbush initiated coverage at Outperform with a $270 objective. Mizuho mirrored Wedbush’s Outperform assessment while establishing a $300 target. Barclays entered with an Overweight rating at $280.
Among all 10 analysts covering the equity, the unified view is Strong Buy. The mean price target stands at $294.
Tuesday’s trading activity registered approximately 1.75 million shares, significantly beneath the stock’s typical volume of around 25 million shares.
Barclays particularly emphasized the OpenAI and Amazon partnerships as transformative for Cerebras within the AI semiconductor landscape.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
